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Abstract
Purpose The aim of this retrospective study was to
evaluate in a historical series of patients whether mor-
phological changes of the urinary tract imaged on intra-
venous urography (IVU) are associated with clinical or
urodynamic data.
Methods During a 1-year period, every man 45 years or
older with lower urinary tract symptoms suggestive of
benign prostatic hyperplasia was systematically evaluated
with multi-channel computer-urodynamic investigation and
IVU. Men with urinary retention, known bladder stones or
diverticula, severely impaired renal function, or allergy to
iodine contrast media were excluded. Structural alterations
of the urinary tract were correlated with clinical and uro-
dynamic data using logistic regression analysis.
Results Data on 203 consecutive patients were available
for analysis. Multivariate analysis demonstrated that the
‘‘ﬁsh-hook’’ conﬁguration of the distal ureter (also known
as ‘‘hockey-stick’’, or ‘‘J-shaped’’ ureter) was the only sign
signiﬁcantly associated with benign prostatic obstruction
(BPO) (odds-ratio 3.64; 95% conﬁdence interval
1.69–7.83; P\0.001). The sensitivity, speciﬁcity, positive
and negative predictive values of the ‘‘ﬁsh-hook’’ ureter
conﬁguration sign to detect BPO was 53, 76, 61 and 70%,
respectively. Bladder trabeculation, upper urinary tract
dilatation, or bladder base elevation were not associated
with BPO, detrusor overactivity, detrusor underactivity,
bladder low-compliance or any clinical data.
Conclusions The ‘‘ﬁsh-hook’’ shape of the distal ureter(s)
indicates BPO and may be a result of prostate median lobe
enlargement.
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Abbreviations
BPH Benign prostatic hyperplasia
BPO Benign prostatic obstruction
BPE Benign prostatic enlargement
CI Conﬁdence interval
IPP Intravesical prostatic protrusion
IPSS International prostate symptom score
IVU Intravenous urography
LUTS Lower urinary tract symptoms
OR Odds ratio




Benign prostatic hyperplasia (BPH) is the term used to
describe the growth of epithelial, muscular and/or ﬁbrotic
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DOI 10.1007/s00345-010-0612-9cells in the prostate [1]. BPH may be associated with
benign prostatic enlargement (BPE), lower urinary tract
symptoms (LUTS) and benign prostatic obstruction (BPO),
although no clear correlations among the components have
been found so far [2–5]. BPH starts affecting men by their
fourth decade and occurs in up to 90% in the ninth decade
[6]. It is ranked ﬁfth among the ten most frequently treated
diseases in Western countries [7] and responsible for a high
socio-economic burden in ageing societies.
Intravenous urography (IVU) is a radiological tool for
the assessment of BPH-related changes of the upper/lower
urinary tract (e.g. hydronephrosis, trabeculation, diverticula
and bladder stones) and other urological diseases (e.g.
nephro-/ureterolithiasis and upper urinary tract tumours).
Despite its excellent diagnostic value, IVU was abandoned
for routine work-up of patients with BPH in most Western
countries in 1990s due to increased radiation risks, costs,
and low additional diagnostic beneﬁt compared to ultra-
sonography [8–11]. Nevertheless, IVU remains a valid tool
to evaluate upper urinary tract pathology (stones, tumours)
and haematuria until today. Therefore, physicians must still
be familiar with IVU to properly judge the urinary tract.
This studyaims toretrospectivelyinvestigate clinicaland
urodynamic data in a cohort of BPH–LUTS patients and
correlate them with IVU signs to evaluate a potential asso-
ciation with morphologicalchanges ofthe urinary tract inan
attempt to contribute to the pathophysiology of the disease.
Materials and methods
Inclusion and exclusion criteria
During 1st January and 31st December 1994, all men aged
C45 years with BPH–LUTS referred to the Department of
Urology, Hannover Medical School were systematically
investigated according to the department policy with (a)
medical history focusing on LUTS, (b) physical (digito-
rectal) examination, (c) International Prostate Symptom
Score (IPSS), (d) urinalysis, (e) laboratory tests including
prostate speciﬁc antigen and creatinine levels, (f) trans-
rectal prostate ultrasound (TRUS), (g) free uroﬂowmetry
and measurement of postvoid residual (PVR) urine, (h)
multi-channel computer-urodynamic investigation (UDI),
and (i) intravenous urography (IVU).
Men with an indwelling bladder catheter, impaired renal
function (serum-creatinine [180 lmol/l), known bladder
stones/diverticula, or allergy to iodine contrast media
received a reduced work-up (a–f). Men with a neurological
deﬁcit, previous lower urinary tract or pelvis operations,
known prostate or transitional cell cancer, or 5a-reductase
inhibitors were excluded. Only men with a complete work-
up (a–i) were included in the study.
Assessment protocol
All investigations were performed as outpatient procedures
during two visits. Medical history, physical examination,
urine as well as blood samples were taken. TRUS was
performed with a 7.5 MHz array and prostate volume was
determined by measuring the greatest transverse and lon-
gitudinal dimensions. Free uroﬂowmetry was done when
the patient reported a full bladder; a minimal voided urine
volume of 150 ml was considered acceptable to judge
maximum urinary ﬂow rate (Qmax). PVR was measured
immediately after voiding using a 3.5 MHz ultrasound
array measuring the greatest bladder transverse and longi-
tudinal distances. Free uroﬂowmetry and PVR measure-
ments were repeated at least once and the highest Qmax/
lowest PVR were used for analysis. Patients were asked to
complete the IPSS questionnaire and deliver their answers
at the second visit.
IVU and UDI were performed one to 3 weeks after
initial presentation if renal function and urinalysis were
appropriate. Three IVU images were taken in the lying
position; the ﬁrst before and the second and third ﬁve and
15 min after contrast media infusion (100 ml Solutrast
TM
300), respectively. UDI was performed using a 7F transu-
rethral microtip and a 12F rectal catheter. The bladder was
ﬁlled with physiological saline solution of 37 C at a rate of
25–50 ml/min. Methods, deﬁnitions and units were in line
with the International Continence Society recommenda-
tions [1]. UDI were conducted at least twice and the lowest
degree of BPO, based on the Scha ¨fer classiﬁcation [12],
was used for analysis.
Evaluation of morphological and functional signs
Structural alterations of the urinary tract on IVU were
correlated with clinical and urodynamic data using logistic
regression analysis. We focused on the following binary
dependent variables based on IVU ﬁndings (Fig. 1): (a)
urinary tract calciﬁcations, (b) delayed excretion of con-
trast media, (c) upper urinary tract dilatation of any degree,
(d) peristalsis of the ureter(s), (e) uni- or bilateral ‘‘ﬁsh-
hook’’ conﬁguration of the distal ureter (‘‘hockey-stick’’ or
‘‘J-shaped’’ ureter), (f) delayed emptying of the ureter(s),
(g) bladder base elevation of any degree, (h) bladder
diverticula unknown prior to investigation and/or
trabeculation.
The following urodynamic variables were tested as
potential predictors of the dependent variables (univariable
analysis): (a) normal/low bladder compliance, (b) presence/
absence of detrusor overactivity, (c) amplitude of unin-
hibited detrusor contractions in patients with detrusor
overactivity, (d) presence/absence of detrusor overactivity
incontinence, (e) normal/week detrusor work during
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123voiding (DAMPF [12]), (f) presence/absence of BPO
(Scha ¨fer nomogram). Signiﬁcant predictors detected were
further evaluated after adjusting for possible confounding
patient characteristics, namely age, prostate volume, PVR
and bladder capacity at UDI.
Results
Data on 203 men were available for analysis. General
patient characteristics and the number of patients with the
speciﬁc IVU or urodynamic ﬁndings are summarized in
Table 1. Univariable binary logistic regression analysis
revealed
• presence of stones was signiﬁcantly associated with low
bladder compliance (OR 3.84, 95% CI: 1.29–11.43;
P = 0.016),
• elevationofthebladderbasewassigniﬁcantlyassociated
with BPO (OR 2.01, 95% CI: 1.14–3.54; P = 0.016),
• ‘‘ﬁsh-hooked’’ conﬁguration of the distal ureter(s) was
signiﬁcantly associated with BPO (OR 3.59, 95% CI:
1.96–6.57; P\0.001).
When potential confounding variables (age, prostate
volume, PVR, and bladder capacity) were taken into
account in the respective multivariate regression models to
test the aforementioned signiﬁcant associations, only the
association between the ‘‘ﬁsh-hook’’ ureter(s) and BPO
remained signiﬁcant (Table 2; models for stones and
bladder base elevation with insigniﬁcant ﬁndings not
shown). Based on the multivariate regression model, BPO
was the only independent predictor of ‘‘ﬁsh-hook’’ ureters.
The sensitivity, speciﬁcity, positive and negative pre-
dictive values of ‘‘ﬁsh-hook’’ ureter(s) to diagnose BPO
was 53, 76, 61 and 70%, respectively, resulting in an
overall test accuracy of 67%. The likelihood ratio of a
positive test result was 2.22 (95% CI 1.51–3.24;
Table 3).
Table 4 demonstrates the general characteristics of
patients with or without the ‘‘ﬁsh-hook’’ sign of the distal
ureter(s) indicating a signiﬁcantly greater prostate volume
and higher serum PSA level in the former subgroup.
Discussion
We investigated in a historical group of unselected patients
with BPH–LUTS the relationship between morphological
and functional signs of the urinary tract, determined by
IVU and UDI, respectively. The ‘‘ﬁsh-hook’’ shape of the
distal ureter(s) was found to be signiﬁcantly associated
with BPO. To the best of our knowledge, we present for the
ﬁrst time urodynamic evidence for this association. The
‘‘ﬁsh-hook’’ ureter has been described in many urological
textbooks [13–15] and was regarded as a sign of BPE
[16, 17].
According to the department policy, every man with
BPH–LUTS was investigated with the identical assessment
protocol in 1994. Only patients with other possible causes
of LUTS and those unsuitable for IVU or UDI were
excluded. Men with known bladder stones, diverticula, or
urinary retention were deprived of UDI because they were
considered obstructed [18] and were submitted directly to
prostate surgery. Consequently, our study group consisted
of 203 consecutive patients who were able to void and
considered to have uncomplicated BPH–LUTS. Inclusion
of more patients might have resulted in selection bias,
because UDI was incomplete during 1991–1993 and IVU
for the routine assessment of patients with BPH–LUTS was
rarely performed in 1995 and ﬁnally abandoned in our
department in 1996. A similar study today using IVU or CT
imaging does not seem to be ethically justiﬁed due to the
Fig. 1 Intravenous urography imaging the urinary tract 15 min after
contrast media infusion showing bilateral ‘‘ﬁsh-hook’’ ureters (?)
and hydronephrosis in an 64-year old men with BPH–LUTS (a)a s
well as a unilateral ‘‘ﬁsh-hook’’ ureter (?) and elevated bladder base
(*) in an 70-year old man with BPH–LUTS (b)
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123risks of radiation but might be conducted using MRI
urography instead. However, ethical approval was not
necessary at that time and therefore not obtained since all
tests were considered necessary for the routine assessment
of patients with BPH–LUTS in 1994.
Our aim was to evaluate the relationships between
morphological and functional changes of the urinary tract
and, therefore, shed light on the pathophysiology of BPH–
LUTS rather than to advertise IVU as a routine test for this
patient group. Although the ‘‘ﬁsh-hook’’ conﬁguration of
Table 1 General patient
characteristics (A) and ﬁndings
on intravenous urography (B) or
computer-urodynamic
investigation (C)
a Based on a free uroﬂow with
voided volume of at least
150 ml
b Deﬁned as involuntary
detrusor contraction(s) with
amplitude C10 cm H2O
c Patients classiﬁed as Scha ¨fer
0, I or II were considered not
obstructed
d More than one sign possible
in a single patient
A. General patient characteristics Median (interquartile range)
Age (years) 63 (13)
Body mass index (kg/m
2) 25.4 (3.8)
International prostate symptom score, IPSS 15 (11)
Quality of life score on IPSS 3 (2)
Serum creatinine level (lmol/l) 87 (22)
Serum prostate speciﬁc antigen concentration (lg/l) 2.1 (3.7)
Prostate volume on transrectal ultrasound (ml) 40 (29)
Maximum ﬂow rate (ml/sec)
a 12.6 (8.2)
Post-void residual urine (ml)
a 50 (122)
Bladder capacity on urodynamic investigation (ml) 345 (279)
B. Speciﬁc signs on intravenous urography Number of affected men
d (%)
Urinary tract calciﬁcations (stones) 17 (8.5)
Urinary tract dilatation (hydronephrosis) 16 (5.5)
Complete ﬁlling of the ureter with contrast media 64 (31.7)
Fish-hook conﬁguration of distal ureter(s), total 72 (36.0)
Unilateral 43 (21.5)
Bilateral 29 (14.5)
Delayed unilateral renal excretion of contrast media 11 (5.4)
Delayed emptying of ureter(s) 6 (3.0)
Bladder base elevation 112 (55.7)
Bladder diverticula and/or trabeculation 49 (24.5)
C. Speciﬁc signs at computer-urodynamic investigation Number of affected men
d (%)
Low bladder compliance (B25 ml/cm H2O) 28 (14.2)
Detrusor overactivity
b 118 (59.3)
Detrusor overactivity incontinence 21 (10.7)
Weak/very weak detrusor work (DAMPF) 11 (5.4)
Benign prostatic obstruction (Scha ¨fer nomogram)
c 83 (40.9)










Age (years) -0.014 0.024 0.986 0.941–1.034 0.565
Prostate volume (ml) -0.003 0.006 0.997 0.985–1.009 0.616
Post-void residual urine(ml) 0.000 0.001 1.000 0.998–1.003 0.835
Bladder capacity (ml) 0.001 0.001 1.001 0.999–1.003 0.221
Benign prostatic obstruction (Scha ¨fer nomogram)
a 1.291 0.391 3.638 1.691–7.827 0.001
Constant (b0) -0.070 1.660 0.933 0.966
Hosmer and lemeshow test: P = 0.329
Two hundred patients were available, whereas three patients without BPO did not show contrast media ﬁlling of the distal ureters and, hence,
were excluded from analysis
Signiﬁcant value is indicated in bold
a Reference category: non obstruction (Scha ¨fer 0, I, II)
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123the distal ureter(s) is signiﬁcantly associated with BPO, this
radiological sign appears unsuitable for routine evaluation
of BPO because its diagnostic value is clearly lower than
that of other non-invasive tests, such as ultrasonic mea-
surements of IPP [19, 20] or detrusor wall thickness [21,
22]. Nevertheless, the knowledge that the ‘‘ﬁsh-hook’’ sign
appears in the presence of BPO might motivate physicians
to evaluate for BPO whenever it is visible.
The ‘‘ﬁsh-hook’’ shape of the distal ureter seems to be
an indirect sign of BPO and might be caused by a prostate
median lobe elevating the trigone, displacing the ureteral
oriﬁce, and deforming the distal ureter. Prostate median
lobe enlargement with intravesical prostatic protrusion
(IPP)[10 mm has been described as a signiﬁcant predictor
of BPO [19, 20]. The association between IPP and BPO
was ﬁrst described in 2003 and, therefore, unknown and not
evaluated in 1994. In contrast to IPP, bladder base eleva-
tion is not only caused by prostate median lobe but also
prostate lateral lobe enlargement; this might explain why
the radiological sign of the elevated bladder base (seen in
55.7% of our patients) was not an independent predictor of
BPO (seen in 40.9% of our patients).
Interestingly, we failed to show signiﬁcant associations
between BPO and other structural alterations of the urinary
tract. Bladder trabeculation showed no association with
BPO or detrusor overactivity; these ﬁndings are in accor-
dance with previous studies [23]. We also could not dem-
onstrate any association between BPO and hydronephrosis;
this stands in contrast to others who demonstrated a
decreasing bladder compliance with increasing BPO grade
[24] and an increasing tendency of upper urinary tract
dilation with decreasing compliance [25]. Since IVU was
not conducted in patients with creatinine levels
[180 lmol/l, the number of patients with bilateral upper
urinary tract dilation (n = 16) without impaired renal
function might have been insufﬁcient to show this rela-
tionship. Bladder stones or diverticula were considered per
se as signs of BPO; these patients were treated by prostate
surgery without UDI. Although bladder stones or diver-
ticula are generally believed to be the result of BPO, only
the association between bladder stones and BPO is evi-
dence based [18].
Conclusions
The ‘‘ﬁsh-hook’’ conﬁguration of the distal ureter(s) is
associated with BPO. Whenever this radiological sign is
detected in older men, for example during routine assess-
ment of urolithiasis or haematuria, the patient should be
evaluated for BPO and counselled accordingly.
Table 3 Distribution of patients with or without ‘‘ﬁsh-hook’’ ure-
ter(s) in the absence or presence of BPO







Two hundred patients were available for evaluation of the test
accuracy of this particular radiological sign; 3 patients without BPO
did not show contrast media ﬁlling of the distal ureters and were
excluded from calculation
a Uni- or bilateral
b Scha ¨fer classes III-VI
c Scha ¨fer classes 0-II
Table 4 Comparison of clinical
data in patients with or without
the ‘‘ﬁsh-hook’’ sign of the
distal ureter
Results are presented as median
(interquartile range)







Age (years) 63.5 (12.0) 62.0 (13.0) 0.410
Body mass index(kg/m
2) 25.2 (3.3) 25.5 (4.3) 0.952
Serum creatinine level (lmol/l) 84 (21) 88 (21) 0.234
International Prostate Symptom
Score, IPSS 1–7
15 (11) 14 (10) 0.828
Quality of life score, IPSS 8 3 (3) 4 (2) 0.305
Serum prostate speciﬁc antigen
(PSA) level (ng/ml)
2.8 (5.9) 1.8 (2.8) 0.028
Prostate volume on transrectal
ultrasound (ml)
44 (37) 36 (22) 0.035
Post-void residual urine (ml) 49 (100) 48 (116) 0.997
Maximum urinary ﬂow rate (ml/sec) 12.0 (4.7) 13.0 (9.4) 0.086
Bladder capacity on urodynamic
investigation (ml)
349 (302) 343 (223) 0.538
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